Telix files form 20-f registration statement for nasdaq ads

Melbourne, australia, oct. 18, 2024 (globe newswire) -- telix pharmaceuticals limited (asx: tlx, telix, the company) announces that it has publicly filed a form 20-f registration statement (registration statement) with the united states (u.s.) securities and exchange commission (sec) relating to a proposed listing of american depository shares (ads), representing the company's ordinary shares, on the nasdaq stock market (nasdaq).
NDAQ Ratings Summary
NDAQ Quant Ranking